173 related articles for article (PubMed ID: 26696553)
1. Carcinogenic Chromium(VI) Compounds Formed by Intracellular Oxidation of Chromium(III) Dietary Supplements by Adipocytes.
Wu LE; Levina A; Harris HH; Cai Z; Lai B; Vogt S; James DE; Lay PA
Angew Chem Int Ed Engl; 2016 Jan; 55(5):1742-5. PubMed ID: 26696553
[TBL] [Abstract][Full Text] [Related]
2. Reactivity of chromium(III) nutritional supplements in biological media: an X-ray absorption spectroscopic study.
Nguyen A; Mulyani I; Levina A; Lay PA
Inorg Chem; 2008 May; 47(10):4299-309. PubMed ID: 18433095
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of a chromium(V) cis-dioxo bis(1,10-phenanthroline) complex and crystal and molecular structures of its chromium(III) precursor.
Weeks CL; Levina A; Dillon CT; Turner P; Fenton RR; Lay PA
Inorg Chem; 2004 Nov; 43(24):7844-56. PubMed ID: 15554650
[TBL] [Abstract][Full Text] [Related]
4. Formation and reactivity of chromium(V)-thiolato complexes: a model for the intracellular reactions of carcinogenic chromium(VI) with biological thiols.
Levina A; Zhang L; Lay PA
J Am Chem Soc; 2010 Jun; 132(25):8720-31. PubMed ID: 20527748
[TBL] [Abstract][Full Text] [Related]
5. X-ray absorption and EPR spectroscopic studies of the biotransformations of chromium(VI) in mammalian cells. Is chromodulin an artifact of isolation methods?
Levina A; Harris HH; Lay PA
J Am Chem Soc; 2007 Feb; 129(5):1065-75. PubMed ID: 17263387
[TBL] [Abstract][Full Text] [Related]
6. Spectroscopic characterization of genotoxic chromium(V) peptide complexes: Oxidation of Chromium(III) triglycine, tetraglycine and pentaglycine complexes.
Headlam HA; Lay PA
J Inorg Biochem; 2016 Sep; 162():227-237. PubMed ID: 27365280
[TBL] [Abstract][Full Text] [Related]
7. X-ray absorption near edge structure and extended X-ray absorption fine structure analysis of standards and biological samples containing mixed oxidation states of chromium(III) and chromium(VI).
Parsons JG; Dokken K; Peralta-Videa JR; Romero-Gonzalez J; Gardea-Torresdey JL
Appl Spectrosc; 2007 Mar; 61(3):338-45. PubMed ID: 17389076
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent uptake, distribution and biotransformation of chromium(VI) in individual and bulk human lung cells: application of synchrotron radiation techniques.
Harris HH; Levina A; Dillon CT; Mulyani I; Lai B; Cai Z; Lay PA
J Biol Inorg Chem; 2005 Mar; 10(2):105-18. PubMed ID: 15714299
[TBL] [Abstract][Full Text] [Related]
9. The effects of hydraulic retention time (HRT) on chromium(VI) reduction using autotrophic cultivation of Chlorella vulgaris.
Lee L; Hsu CY; Yen HW
Bioprocess Biosyst Eng; 2017 Dec; 40(12):1725-1731. PubMed ID: 28871394
[TBL] [Abstract][Full Text] [Related]
10. Comparative histological studies on liver of mice exposed to Cr(VI) and Cr(V) compounds.
das Neves RP; Santos TM; Pereira Mde L; de Jesus JP
Hum Exp Toxicol; 2002 Jul; 21(7):365-9. PubMed ID: 12269698
[TBL] [Abstract][Full Text] [Related]
11. Isolation, characterization, and nuclease activity of biologically relevant chromium(V) complexes with monosaccharides and model diols. Likely intermediates in chromium-induced cancers.
Bartholomäus R; Irwin JA; Shi L; Smith SM; Levina A; Lay PA
Inorg Chem; 2013 Apr; 52(8):4282-92. PubMed ID: 23531300
[TBL] [Abstract][Full Text] [Related]
12. Chemical properties and toxicity of chromium(III) nutritional supplements.
Levina A; Lay PA
Chem Res Toxicol; 2008 Mar; 21(3):563-71. PubMed ID: 18237145
[TBL] [Abstract][Full Text] [Related]
13. Solution structures of chromium(VI) complexes with glutathione and model thiols.
Levina A; Lay PA
Inorg Chem; 2004 Jan; 43(1):324-35. PubMed ID: 14704084
[TBL] [Abstract][Full Text] [Related]
14. Reduction and immobilization of chromium(VI) by iron(II)-treated faujasite.
Kiser JR; Manning BA
J Hazard Mater; 2010 Feb; 174(1-3):167-74. PubMed ID: 19796874
[TBL] [Abstract][Full Text] [Related]
15. Chromium oxidation state imaging in mammalian cells exposed in vitro to soluble or particulate chromate compounds.
Ortega R; Fayard B; Salomé M; Devès G; Susini J
Chem Res Toxicol; 2005 Oct; 18(10):1512-9. PubMed ID: 16533014
[TBL] [Abstract][Full Text] [Related]
16. Oxochromium(V) species formed with 2,3-dehydro-2-deoxy-N-acetylneuraminic or N-acetylneuraminic (sialic) acids: an in vitro model system of oxochromium(V) species potentially stabilized in the respiratory tract upon inhalation of carcinogenic chromium(VI) compounds.
Codd R; Lay PA
Chem Res Toxicol; 2003 Jul; 16(7):881-92. PubMed ID: 12870891
[TBL] [Abstract][Full Text] [Related]
17. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach.
Poljsak B; Gazdag Z; Jenko-Brinovec S; Fujs S; Pesti M; Bélagyi J; Plesnicar S; Raspor P
J Appl Toxicol; 2005; 25(6):535-48. PubMed ID: 16092082
[TBL] [Abstract][Full Text] [Related]
18. A novel strategy for Cr(III) and Cr(VI) analysis in dietary supplements by speciated isotope dilution mass spectrometry.
Unceta N; Astorkia M; Abrego Z; Gómez-Caballero A; Goicolea MA; Barrio RJ
Talanta; 2016 Jul; 154():255-62. PubMed ID: 27154672
[TBL] [Abstract][Full Text] [Related]
19. Cr(VI) reduction by a potent novel alkaliphilic halotolerant strain Pseudochrobactrum saccharolyticum LY10.
Long D; Tang X; Cai K; Chen G; Chen L; Duan D; Zhu J; Chen Y
J Hazard Mater; 2013 Jul; 256-257():24-32. PubMed ID: 23669787
[TBL] [Abstract][Full Text] [Related]
20. Carcinogenic chromium(VI)-induced protein oxidation and lipid peroxidation: implications in DNA-protein crosslinking.
Mattagajasingh SN; Misra BR; Misra HP
J Appl Toxicol; 2008 Nov; 28(8):987-97. PubMed ID: 18615841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
